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Abstract. 
 
Stratiﬁed epithelium displays an equilibrium 
between proliferation and cell cycle arrest, a balance 
that is disrupted in basal cell carcinoma (BCC). Sonic 
hedgehog (Shh) pathway activation appears sufﬁcient 
to induce BCC, however, the way it does so is un-
known. Shh-induced epidermal hyperplasia is accompa-
nied by continued cell proliferation in normally growth 
arrested suprabasal cells in vivo. Shh-expressing cells 
fail to exit S and G2/M phases in response to calcium-
induced differentiation and also resist exhaustion of 
replicative growth capacity. In addition, Shh blocks 
p21
 
CIP1/WAF1
 
-induced growth arrest. These data indicate 
that Shh promotes neoplasia by opposing normal stim-
uli for epithelial cell cycle arrest.
Key words: Sonic hedgehog • epidermis • cell cycle 
regulation • basal cell carcinoma • cyclin-dependent ki-
nase inhibitor
 
I
 
DENTIFIED
 
 as an important regulator of segment polar-
ity and tissue organization in 
 
Drosophila
 
 (14), the
hedgehog signal transduction pathway can play a sig-
nificant role in human disease (1, 15, 27). Mutations in
hedgehog pathway genes have been associated with human
basal cell carcinoma (BCC)
 
1
 
 (13, 16, 29), and hedgehog
pathway activation alone is sufficient to induce epidermal
neoplasms indistinguishable from BCC in transgenic mu-
rine (25) and human skin (11). The basis for these potent
neoplastic effects are not fully understood. Specifically,
the effects of Shh on cell growth regulation in this context
have not been studied.
Here we report that Shh promotes cellular proliferation
by opposing triggers for physiologic epithelial growth ar-
rest. In addition, we demonstrate that Shh augments the
replicative capacity of normal human epithelial cells. The
results of these studies identify a new role for Shh in cell
cycle regulation and provide a mechanistic basis for Shh
induction of epithelial neoplasia.
 
Materials and Methods
 
Genetically Engineered Human Skin
 
Early passage normal human keratinocytes were transduced with retrovi-
ral expression vectors for Shh-IRES-GFP as well as GFP and lacZ con-
trols as noted below and seeded on devitalized human dermis and grafted
to SCID mice (5). 4 mice were grafted per vector group; untransduced ke-
ratinocytes as well as GFP and lacZ vectors groups were used as addi-
tional controls. At 1 and 3 wk, a biopsy was performed and 5-
 
m
 
M-thick tis-
sue cryosections were prepared. The human species origin of regenerated
epithelium was confirmed in tissue sections using species-specific antibod-
ies to human involucrin (24) (BTI Inc.). Propidium iodide staining was
performed to highlight cellular nuclei in Shh and GFP control human epi-
dermis at 1 and 3 wk using propidium iodide at 40 ng/ml for 1 min. For
study of indicators of cellular proliferation in vivo, bromodeoxyuridine
(BrdU) (Sigma) 100 mg/kg was administered by intraperitoneal injection
to mice bearing genetically engineered human skin grafts. 2 h after injec-
tion, human skin was excised and 5-
 
m
 
M cryosections prepared. Antibody
staining for BrdU (Becton Dickinson) and Ki-67 (Novocastra) was per-
formed as described (28). Quantitation of fold increase in BrdU[
 
1
 
] and
Ki-67[
 
1
 
] cell numbers per 100 
 
m
 
M unit surface length was performed at 1
and 3 wk, with GFP epidermis at 1 wk assigned the standard value of 1.0.
Error bars were calculated as SD between four independent grafts in each
vector group.
 
Cell Culture and Gene Transfer
 
Primary human keratinocytes were freshly isolated from human skin (26)
and transduced with retroviral expression vectors for Shh-IRES-GFP as
well as GFP and lacZ controls (7, 11). Greater than 99% efficiency of both
gene transfer and gene expression maintenance was verified by fluores-
 
cence microscopy (or X-gal staining at pH 8.0 for 
 
E
 
.
 
 coli
 
 lacZ), both at
48 h after transduction and at serial passaging to passage 15 as previously
described (7, 11). A similar gene transfer approach was used for the hu-
man p21
 
Cip1
 
 retroviral expression vector except that high efficiency gene
transfer was confirmed by immunofluorescence staining of cell aliquots
using antibodies to p21
 
Cip1
 
 (Santa Cruz Biotechnology). For p21
 
Cip1
 
 stud-
ies, transduction with p21
 
Cip1
 
 retroviral expression vectors was performed
48 h after initial transduction with either Shh-IRES-GFP or GFP and lacZ
controls. Senescence-associated 
 
b
 
-galactosidase (SA-
 
b
 
-gal) expression
was determined at pH 6.0 as described (9) before and at day 0, 3, 5, 7, and
9 after transduction with retroviral vector for expression of p21
 
Cip1
 
. Kera-
tinocytes were used from the same donor for each series of experiments to
control for possible tissue variations between individuals. All experiments
were performed using triplicate independent transductions, with data pre-
sented as the average of these independent transductions 
 
6 
 
SD.
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Cell Cycle Analysis
 
Cell cycle distribution was determined in proliferating cells grown in a 1:1
mixture of SFM media (GIBCO BRL) and 154 media (Cascade Biologics)
growth media as described (28). Terminal differentiation-associated
growth inhibition was induced by addition of 1.5 mM calcium to this me-
dia for 48 h. Shh and control cells were stained with propidium iodide and
analyzed for DNA content via flow cytometry (23).
 
Cell Growth and Replicative Capacity 
 
Cumulative cell yield was determined as previously described (17), with
cells grown in a low calcium 1:1 media mixture of SFM:154 media (28).
Cells were passaged at identical densities in triplicate after triplicate inde-
pendent transductions for each condition. Each independent transduction
was passaged separately after initial gene transfer, with the average cell
numbers 
 
6 
 
SD presented for each condition. Three independent series of
these long-term experiments were performed to assess replicative capacity
and cumulative cell yield.
 
Analysis of CDK2 and CDK4
 
Analysis of CDK2 and CDK4 kinase activity was performed as previously
described (20). In brief, cells were rinsed with cold PBS and harvested in
lysis buffer (50 mM Hepes pH 7.5, 150 mM NaCl, 2.5 mM EGTA, 1 mM
EDTA, and 0.1% Tween-20 with 1 mM DTT, 0.1 mM PMSF, 0.2 U/ml
aprotinin, 10 mM 
 
b
 
-glycerophosphate, 0.1 mM sodium orthovanadate,
and 1 mM sodium fluoride). After a freeze-thaw cycle, lysates were col-
lected after centrifugation at 12,000 
 
g
 
 for 10 min and immunoprecipitated
using antibodies to human CDK2 and CDK4 (Santa Cruz). Histone H1
Figure 1. Shh promotes epithe-
lial proliferation in vivo. Human
epidermis genetically engi-
neered to express Shh and GFP
control  was regenerated on
SCID mice. For all studies
data presented is the average of
three independent grafts each
for Shh and control 6 SD. (a)
Propidium iodide staining to
highlight cellular nuclei in Shh
and GFP control human epider-
mis. Quantitation of fold in-
crease in cell numbers per 100
mM unit surface length at 1 and
3 wk is shown at right. (b) Ki-67
proliferation marker expression
by immunoperoxidase staining
at 3 wk, counterstaining with
methyl green; quantitation of
fold increase in cell numbers per
100  mM unit surface length is
shown at right. Note positive
cells (dark nuclei) well above
the basement membrane zone
in Shh[1] epidermis. (c) BrdU
labeling of Shh and control hu-
man epidermis at 3 wk; quanti-
tation of fold increase in cell
numbers per 100 mM unit sur-
face length is shown at right.
Bars: (a) 100 mM; (b) 75 mM; (c)
50 mM. 
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(Boehringer-Mannheim) was used as a substrate for kinase assays in 50 mM
Hepes, pH 7.0, 10 mM MgCl
 
2
 
, 2.5 mM EGTA, 1 mM DTT, 20 
 
m
 
M ATP,
10 mM 
 
b
 
-glycerophosphate, 0.1 mM sodium orthovanadate, and 1 mM so-
dium fluoride. The amount of CDK2 and CDK4 protein in precipitates
was confirmed in parallel by immunoblotting.
 
Results
 
Shh Promotes Epithelial Proliferation In Vivo
 
To determine if Shh impacts epithelial cell cycle regula-
tion, we expressed Shh in human epidermis regenerated
on immune deficient mice from normal keratinocytes in an
approach known to effect hedgehog pathway activation
(11). Genetically engineered human epidermal grafts were
then examined at 1 and 3 wk after grafting. Compared
with normal findings seen in GFP[
 
1
 
] and lacZ[
 
1
 
] con-
trols, Shh[
 
1
 
] epidermis displays hyperplasia and an over
sixfold increase in cell numbers per unit surface length by
3 wk (Fig. 1 a). Shh[
 
1
 
] epidermis is hyperproliferative,
with 
 
.
 
10-fold increases in Ki-67 expression and 
 
.
 
8-fold
increase in BrdU incorporation compared with controls
(Fig. 1, b and c). Even in Shh[
 
1
 
] tissue sections with com-
parable thickness to control, Ki-67- and BrdU-positive
cells are seen well above the basal layer of Shh[
 
1
 
] epider-
mis (Fig. 1 b), suggesting a failure to undergo the cell cycle
arrest that normally occurs before outward migration in
stratified epithelium. Such findings raise the possibility
that Shh may oppose stimuli for epithelial cell cycle arrest.
 
Shh-expressing Cells Fail to Appropriately Exit S and 
G2/M Phases in Response to
Calcium-induced Differentiation
 
To determine if Shh confers a resistance to differentiation-
associated cell cycle arrest, Shh[
 
1
 
] and control cells were
grown to confluence in vitro then media calcium concen-
tration was raised to 1.5 mM in a process that recapitulates
features of differentiation seen in vivo, including cell cycle
arrest and activation of certain terminal differentiation
genes (18). Cell cycle distribution was analyzed both be-
fore differentiation stimuli and 48 h after addition of cal-
cium. Shh[
 
1
 
] and control cells are indistinguishable under
low calcium conditions promoting cellular proliferation,
with the majority of cells in G2/M and S phase (Fig. 2). As
anticipated, the addition of calcium induces exit of the ma-
jority of normal control cells into G0/G1. Whereas Shh[
 
1
 
]
cells alter their cell cycle distribution in response to cal-
cium, instead of redistributing to G0/G1 these cells are dis-
proportionately in G2/M and S phase (Fig. 2). These find-
ings indicate Shh opposes cell cycle inhibitory effects of a
primary in vitro stimulus for epithelial differentiation.
 
Shh Augments Cell Capacity for Long-Term Growth
 
These findings suggest that Shh pathway activation may
confer resistance to growth inhibitory mechanisms that are
of potential importance in epithelial growth control and
neoplasia. To test if Shh augments the long-term growth
capacity of nonimmortalized human epithelial cells, we
performed serial passaging of Shh[
 
1
 
] cells along with
GFP- and lacZ-expressing controls. Nonimmortalized ke-
ratinocytes exhaust their replicative capacity after multi-
 
ple passages in vitro, allowing the total cell yield of a de-
fined number of input cells to be determined (17, 19).
Shh[
 
1
 
] cells display more active sustained proliferation,
growing to higher densities and demonstrating evidence of
more active DNA replication compared with controls (Fig.
3, a and b). Consistent with this, Shh[
 
1
 
] cells generate a
cumulative increased cell yield of 64–150-fold over con-
trols before exhaustion of replicative capacity (Fig. 3
c). Shh[
 
1
 
] cells continue to proliferate until passage 16
whereas controls cease active proliferation after passage
12. Less than 5% of cells were nonviable at each passage
for all groups (as judged by trypan blue exclusion), indicat-
ing that this increase is not due to alterations in frequency
of cell death. These findings indicate that Shh augments
the proliferative capacity of normal epithelial cells.
 
Shh Antagonizes p21
 
Cip1
 
-induced Growth Arrest
 
Another negative growth regulatory mechanism bypassed
in neoplasia are cyclin-dependent kinase inhibitors (CKIs).
To determine if Shh could also confer resistance to CKI-
induced growth arrest, we studied its impact on the effects
of p21
 
Cip1
 
, a CKI of known importance in epithelial growth
inhibition (8, 23). p21
 
Cip1
 
 is known to be important in the
cell growth arrest that occurs before keratinocyte terminal
differentiation (8, 23). Shh[
 
1
 
] and control cells were trans-
duced at high efficiency with a retroviral expression vector
Figure 2. Shh-expressing cells fail to appropriately exit S and
G2/M phases in response to calcium-induced differentiation. Cell
cycle distribution was determined in cells in low calcium growth
media and in cells undergoing calcium-induced differentiation in
vitro via elevation of the media calcium concentration to 1.5 mM.
Shh and GFP control cells were analyzed for DNA content via
flow cytometry. (a) Control, growth media. (b) Shh[1], growth
media. (c) Control, 1.5 mM calcium. (d) Shh[1] 1.5 mM calcium.
Representative plots are shown; accompanying percentage fig-
ures represent the averages of three independent transductions
and flow cytometric analyses for Shh and controls 6 SEM 
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for p21
 
Cip1
 
 and kinetics of cell growth were determined. As
anticipated, p21
 
Cip1
 
 profoundly inhibits proliferation of
both untransduced and GFP[
 
1
 
] control cells, however,
p21
 
Cip1
 
 expression fails to inhibit exponential growth by
Shh[
 
1
 
] cells (Fig. 4 a). In addition to resisting p21
 
Cip1
 
growth arrest, Shh[
 
1
 
] cells fail to induce a biomarker seen
in permanent cell cycle arrest, SA-
 
b
 
-gal (9), in response to
p21
 
Cip1
 
. Whereas 
 
z
 
50% of control cells are SA-
 
b
 
-gal[
 
1
 
]
by day 5, only 15% of Shh[
 
1
 
] cells express this biomarker
(Fig. 4 b). Shh expression in these cells is also associated
with augmented levels of CDK2 and CDK4 associated ki-
nase activity, with this activity not fully repressed by
p21
 
Cip1
 
 in the case of CDK2 (Fig. 4 c). These data indicate
that Shh opposes p21
 
Cip1
 
-induced growth arrest and sug-
gest that Shh leads to activation of key core cell cycle ma-
chinery elements CDK2 and CDK4.
 
Discussion
 
Cell cycle exit before outward migration and terminal dif-
ferentiation is a cardinal feature of normal stratified epi-
thelium. Here we report that Shh inhibits this process. We
observe that Shh induces dramatic increases in the propor-
tion of actively proliferating cells within stratified epi-
thelium, including cells in normally growth-arrested
suprabasal layers. This observation suggests that Shh op-
poses the normal growth arrest necessary for homeostasis
in stratified epithelium. Implicated as important in this
growth arrest process in vivo are calcium and the CKI
p21
 
Cip1
 
. Consistent with this, we found that Shh rendered
cells resistant to the exit from S and G2/M that occurs in
normal keratinocytes exposed to elevated calcium concen-
trations in vitro in a process that may recapitulate the local
differences in calcium concentration that exist within nor-
mal epidermis (10). This resistance was characterized by
an enhanced accumulation of cells in G2/M, raising the
possibility that Shh could impact regulators acting at later
points in the cell cycle. In addition to calcium, another
factor implicated in the promotion of normal epithelial
growth arrest is the CKI p21
 
Cip1
 
 (8). Shh also opposes
p21
 
Cip1
 
 growth inhibitory effects, raising the possibility
that Shh may exert a dominant positive impact on core cell
cycle machinery capable of bypassing negative signals
from CKIs.
The possibility that Shh acts dominantly on core cell cy-
cle machinery is supported by the observation that Shh ex-
pression is associated with an increase in activity of CDK2
and CDK4 under normal growth conditions. This is most
notable in the case of CDK2 whose inhibition by p21
 
Cip1
 
 is
an important control point in the G1-S transition (3).
Shh[
 
1
 
] cells sustain CDK2 activity even in the presence of
p21
 
Cip1
 
, although the undetectable levels of CDK2 kinase
activity in controls make conclusions about relative impact
of Shh on p21
 
Cip1
 
 inhibition of CDK2 difficult. Detailed
knowledge of the impact of loss of Shh pathway function
on mammalian epithelial cell growth in settings where it is
normally active, is not currently available. The failure of
hair follicle morphogenesis in mice lacking Shh (4), how-
ever, suggests that such loss may lead to a failure of the ep-
ithelial cell expansion required in this process. Consistent
Figure 3. Shh augments cell
capacity for long-term
growth. (a) Methylene blue
stain of plates of normal hu-
man epithelial cells express-
ing Shh as well as GFP and
lacZ controls after passaging
at identical densities, shown
at 4 d after plating at passage
11. Note the increased cell
density and staining in Shh
plates compared with con-
trols; duplicate independent
transductions passaged sepa-
rately for the duration of
the experiment are shown.
(b) BrdU incorporation of
Shh[1] cells over a 2-h time
period compared with GFP
and lacZ (LZRS) controls.
Immunofluorescence staining
was performed using anti-
body to BrdU (green) and
counterstaining with propid-
ium iodide to visualize all
cells in the field (red). BrdU labeling index 5 number of BrdU[1] cells/total cell number at passage 11 was calculated in three indepen-
dent transductions with quantitation shown at bottom of each panel. (c) Cumulative cell yield of Shh[1] as well as GFP and lacZ con-
trols was determined after exhaustion of proliferative capacity. The insert shows an expanded scale to more clearly denote the cell yield
for controls. Data represents mean total cell yield for three independent experiments 6 SEM. (d) Confirmation of retained gene ex-
pression in Shh[1] cells as well as controls. mRNA was prepared from GFP[1], lacZ[1] and Shh[1] cells as well as untransduced con-
trols ([2]) at their final passages and subjected to RT-PCR. (Top) Shh cDNA-specific primers. (Bottom) Primers for the c1 retroviral
packaging sequence common to all vectors. 
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with these data, our findings indicate that Shh enhances
epithelial proliferation and opposes stimuli for normal cell
cycle exit.
Evidence of Shh pathway activation is present in the
vast majority of human BCCs, with induction of the Shh
target Gli1 a consistent finding even in the absence of ab-
normal Shh or Ptc expression (6). The fact that misexpres-
sion of Gli1 alone can induce tumors in vertebrate em-
bryos in the absence of primary perturbations in Shh
expression (6) underscores the fact that Shh pathway
downstream effectors may account for the impact of in-
duced Shh expression observed in these studies.
Unlike the classical step-wise model of carcinogenesis
requiring multiple genetic lesions, hedgehog pathway acti-
vation alone appears sufficient to produce cardinal fea-
tures of human BCC (11). This observation may account
for the fact that BCC arises without precursor lesions, un-
like another common cancer of stratified epithelium, cuta-
neous squamous cell carcinoma (22). In light of the mecha-
nism of Shh pathway induction, it is possible these effects
may occur within normal hair-bearing skin and in BCC in
a non-cell autonomous manner. This single hit induction
of neoplasia by Shh stands in sharp contrast to the step-
wise model of carcinogenesis requiring multiple genetic al-
terations believed for some time to be operative in other
neoplasias, such as colorectal carcinoma (12). In addition,
this proposed requirement for activation of only one path-
way to trigger this cancer may offer an explanation as to
why BCC is the most common malignancy in the United
States, with an estimated incidence of up to 1,000,000
yearly (21).
Recent studies support a need for cells to surmount sev-
eral major obstacles in order to progress to neoplasia; apop-
tosis and irreversible growth arrest have emerged as two
of the most important of these obstacles (30). We have
found that Shh augments cellular capacity for long-term
growth. The fact that Shh opposes p21
 
Cip1
 
-induced growth
arrest is consistent with this observation as p21
 
Cip1
 
 loss al-
lows other cell types to resist replicative exhaustion (2).
The Shh effects on growth capacity observed here, how-
ever, may likely be due to Shh-enhanced resistance to ter-
minal differentiation-associated cell cycle arrest rather
than a direct extension of the Hayflick limit on population
doublings. Combined with the ability of Shh to induce
bcl-2 (11), and thus potentially resist apoptosis, the ability
to bypass growth arrest stimuli shown has been increas-
ingly recognized as an important milestone in carcinogen-
esis and may explain the potent effects of the Shh pathway
in inducing BCC. In spite of these potent effects, Shh-
induced neoplasia appears to lack the aggressiveness of
other malignancies characterized by multiple genetic le-
sions. In general, BCCs are slowly growing tumors that do
not exhibit markedly invasive features and characteristi-
cally fail to metastasize (22). These biologically mild be-
havioral characteristics may be due to the fact that BCC
lacks the additional genetic lesions necessary for more ag-
gressive behavior.
Our findings indicate that Shh action promotes cellular
proliferation by opposing cell cycle arrest. This observa-
tion may provide a platform for future studies examining
Shh impacts on cell growth during development as well as
in efforts aimed at defining the mechanistic basis of nor-
mal growth control in epithelial tissues.
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Figure 4. Shh antagonizes p21Cip1-induced growth arrest. (a) Cell
growth after p21Cip1 expression. 2 d after high efficiency gene
transfer with Shh or GFP retroviral expression vectors, normal
human epithelial cells were transduced in triplicate independent
transductions at high efficiency with a retroviral expression vec-
tor for human p21Cip1 and cell numbers determined in the days
following. Data is expressed from triplicate independent trans-
ductions 6 SEM (b) SA-b-gal induction. Proportion of cells
expressing SA-b-gal after p21Cip1 gene transfer. Arrows denote
representative SA-b-gal[1] cells. Quantitation of percent SA-
b-gal[1] cells 6 SEM from three independent transductions is
shown at right. (c) Shh effect on CDK2 and CDK4 kinase activ-
ity. Extracts from normal human epithelial cells transduced with
retroviral expression vectors for Shh, GFP control as well as
those cotransduced with vectors for either both Shh and p21Cip1
or GFP and p21Cip1 were immunoprecipitated using antibodies to
CDK2 and CDK4. Kinase activity (top panels) was measured us-
ing histone H1 as a substrate. Immunoblotting was also per-
formed in parallel to demonstrate the amount of CDK2 and
CDK4 protein present in the precipitate (bottom panels below
kinase activity).The Journal of Cell Biology, Volume 147, 1999 76
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